Advancing health equity in clinical trials by addressing financial burden

The ability to effectively recruit and retain patients has a major impact on clinical trials timelines. And, for many patients, the financial burden from loss of income for missed work, the cost of transportation/travel for study-related appointments, childcare costs, etc. impacts their ability to join or remain in a trial. 

In this video, patient engagement and clinical development experts discuss changing the industry paradigm by creating new industry standards that are fair, ethical, and meaningful to patients, simple for sites to implement, and with potential to expand into other countries. By standardizing and simplifying, we can positively influence adoption to improve patient recruitment, retention, and experience.

Return to Insights Center

Related Insights

Article

3 ways to incorporate DE&I in your communications strategy

Sep 29, 2021

Webinar

In Conversation: Leadership Lessons on Diversity, Equity, & Inclusion, and the Future of Work

Apr 29, 2021

Blog

Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients

Sep 23, 2022

Blog

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

Apr 25, 2022

Podcast

Decentrally Speaking | Episode 1: Optimizing Trial Inclusivity For Patients From Under-Represented Communities

Mar 22, 2022

Blog

Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey

Jan 24, 2024

Blog

Parexel names first Patient Ambassador

Jun 17, 2022

Blog

Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

May 3, 2022

Blog

Patients as Partners 2022: Moving from Insights to Action

May 3, 2022

Blog

Six steps to maximize inclusivity within medical communications | Part 1: Race and Ethnicity

Mar 3, 2022

Blog

CNS Summit Recap: The Future is Collaborative

Nov 22, 2021

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021